PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 90 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $359,000 | +2.9% | 139,900 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $349,000 | +20.8% | 139,900 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $289,000 | -33.3% | 139,900 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $433,000 | +36.2% | 139,900 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $318,000 | -37.2% | 139,900 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $506,000 | -29.5% | 139,900 | -33.7% | 0.00% | 0.0% |
Q3 2019 | $718,000 | +35.5% | 211,000 | +86.9% | 0.00% | 0.0% |
Q2 2019 | $530,000 | +51.0% | 112,900 | +7.5% | 0.00% | 0.0% |
Q1 2019 | $351,000 | +25.8% | 105,000 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $279,000 | -52.6% | 105,000 | 0.0% | 0.00% | -66.7% |
Q3 2018 | $588,000 | +10.5% | 105,000 | 0.0% | 0.00% | +50.0% |
Q2 2018 | $532,000 | -16.4% | 105,000 | +12.4% | 0.00% | -33.3% |
Q1 2018 | $636,000 | -25.3% | 93,400 | -17.2% | 0.00% | -25.0% |
Q4 2017 | $851,000 | +1393.0% | 112,800 | +1028.0% | 0.00% | – |
Q3 2017 | $57,000 | +14.0% | 10,000 | 0.0% | 0.00% | – |
Q2 2017 | $50,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |